Abstract:The expression and subsequent purification of mammalian recombinant proteins is of critical importance to many areas of biological science. To maintain the appropriate tertiary structure and post-translational modifications of such proteins, transient mammalian expression systems are often adopted. The successful utilisation of these systems is, however, not always forthcoming and some recombinant proteins prove refractory to expression in mammalian hosts. In this study we focussed on the role of different N-terminal signal peptides and residues immediately downstream, in influencing the level of secreted recombinant protein obtained from suspension HEK293 cells. Using secreted alkaline phosphatase (SEAP) as a model protein, we identified that the +1/+2 downstream residues flanking a heterologous signal peptide significantly affect secreted levels. By incorporating these findings we conducted a comparison of different signal peptide sequences and identified the most productive as secrecon, a computationally-designed sequence. Importantly, in the context of the secrecon signal peptide and SEAP, we also demonstrated a clear preference for specific amino acid residues at the +1 position (e.g. alanine), and a detrimental effect of others (cysteine, proline, tyrosine and glutamine). When proteins that naturally contain these "undesirable" residues at the +1 position were expressed with their native signal peptide, the heterologous secrecon signal peptide, or secrecon with an additional alanine at the +1 or +1 and +2 position, the level of expression differed significantly and in an unpredictable manner. For each protein, however, at least one of the panel of signal peptide/adjacent amino acid combinations enabled successful recombinant expression. In this study, we highlight the important interplay between a signal peptide and its adjacent amino acids in enabling protein expression, and we describe a strategy that could enable recombinant proteins that have so far proved refractory to expression in HEK293 cells, to be produced in sufficient quantities to answer important biological questions.

Overexpression and Purification of Recombinant Atrial Natriuretic Peptide Using Hybrid Fusion Protein REF-ANP in Escherichia Coli

[High Level Expression of Human Atrial Natriuretic Peptide in Fusion Form in E. Coli System].

Expression and purification of a novel therapeutic single-chain variable fragment antibody against BNP from inclusion bodies of Escherichia coli

Expression and Purification of Angiogenin-Egfp Fusion Protein in E.coli

Refolding and Purification of Recombinant Human (pro)renin Receptor from Escherichia Coli by Ion Exchange Chromatography

Use of Ssp dnaB derived mini-intein as a fusion partner for production of recombinant human brain natriuretic peptide in Escherichia coli

Expression and purification of human urodilatin by small ubiquitin-related modifier fusion in Escherichia coli

Purification, sequencing and synthesis of natriuretic and vasoactive rat atrial peptide

Prokaryotic Expression Purification and Identification of Human Amino-Terminal Pro-Brain Natriuretic Peptide and Its Stability

Refolding and two-step purification by hydrophobic interaction chromatography of recombinant human bone morphogenetic protein-2 from Escherichia coli

Cloning, Construction and Purification of Recombinant Human B-type Natriuretic Peptide

Efficient and easily scalable protein folding strong anion exchange chromatography for renaturation and simultaneous purification of recombinant human asparaginase from E. coli

Heterologous high yield expression and purification of neurotensin and its functional fragment in Escherichia coli

Separation of recombinant human vasoactive intestinal peptide–humanin fusion protein via three different approaches

High-Level Production of a Novel Antimicrobial Peptide Perinerin in Escherichia Coli by Fusion Expression

High-level expression and purification of a nonmitogenic form of human acidic fibroblast growth factor in Escherichia coli.

Overcoming the Refractory Expression of Secreted Recombinant Proteins in Mammalian Cells through Modification of the Signal Peptide and Adjacent Amino Acids

A pH-induced, intein-mediated expression and purification of recombinant human epidermal growth factor in Escherichia coli

An Automatic Refolding Apparatus for Preparative-Scale Protein Production

Refolding and Purification of Recombined Human Endostatin Using Cation Exchange Chromatography

Expression and Purification of Soluble Human Neutrophil Gelatinase Associated Lipocalin in E.coli